Kura Oncology Inc. said Heidi Henson is stepping down as CFO and company secretary July 6 to pursue other opportunities.
Henson agreed to serve as a consultant to the company following her resignation. Troy Wilson, Kura Oncology's CEO and president, will act as interim principal financial officer and principal accounting officer following Henson's departure.
Henson had been serving as secretary and CFO of the San Diego-based cancer-drug maker since August 2014.
Kura Oncology said it is looking for a new CFO.
